Soluble Guanylate Cyclase Stimulator Vericiguat Enhances Long-Term Memory in Rats without Altering Cerebral Blood
Ellis Nelissen1, Elentina K Argyrousi1, Nick P Van Goethem1
1Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNS), Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, The Netherlands.
Vericiguat, a soluble guanylate cyclase stimulator, improved long-term memory and hippocampal plasticity in rats. This suggests potential for treating vascular cognitive impairment, particularly when the blood-brain barrier is compromised.
Area of Science:
- Neuroscience
- Pharmacology
- Cardiovascular Science
Background:
- Vascular cognitive impairment (VCI) involves impaired cerebral blood flow, endothelial function, and blood-brain barrier (BBB) integrity.
- The nitric oxide (NO)-soluble guanylate cyclase (sGC)-cGMP pathway regulates these processes and is crucial for memory formation via long-term potentiation (LTP).
Purpose of the Study:
- To investigate the potential of the sGC stimulator vericiguat as a cognitive enhancer for VCI.
- To assess vericiguat's effects on long-term memory, hippocampal plasticity, and physiological parameters in a rat model.
Main Methods:
- Long-term memory was evaluated using an object location task in rats.
- Hippocampal plasticity was assessed ex vivo using a chemical LTP model.
- Peripheral effects were measured by monitoring blood pressure and cerebral blood volume.
Main Results:
- Vericiguat enhanced long-term memory and hippocampal plasticity, evidenced by increased AMPA receptor translocation.
- The drug did not significantly alter blood pressure or cerebral blood volume.
- Low brain-penetrance of vericiguat was observed.
Conclusions:
- sGC stimulation with vericiguat shows promise as a therapeutic strategy for VCI.
- Memory enhancement may stem from peripheral effects on cerebral microvasculature, especially beneficial in cases of reduced BBB integrity.
More Related Videos
08:44Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
Published on: September 1, 2016
05:12A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
Published on: November 22, 2024
